Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease

NCT00876863 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: CERE-110: Adeno-Associated Virus injection Surgery
PROCEDURE: Placebo Surgery

Sponsor

Sangamo Therapeutics

Collaborators

[object Object]